Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers

  • Anixa Biosciences (NASDAQ:ANIX) stock moved upwards by 9.1% to $3.35 during Tuesday's after-market session. The company's market cap stands at $100.9 million.
  • Exicure (NASDAQ:XCUR) shares increased by 7.4% to $0.17. This security traded at a volume of 1.3 million shares come close, making up 36.6% of its average volume over the last 100 days. The market value of their outstanding shares is at $18.9 million.
  • Avinger (NASDAQ:AVGR) shares moved upwards by 5.12% to $0.31. The market value of their outstanding shares is at $29.6 million.
  • Verastem (NASDAQ:VSTM) stock rose 4.79% to $1.75. The company's market cap stands at $318.8 million.
  • CASI Pharmaceuticals (NASDAQ:CASI) stock rose 4.04% to $0.65. The market value of their outstanding shares is at $90.8 million.
  • BeyondSpring (NASDAQ:BYSI) stock increased by 3.91% to $3.45. The company's market cap stands at $135.0 million.

Losers

  • Palisade Bio (NASDAQ:PALI) stock decreased by 6.3% to $1.05 during Tuesday's after-market session. The market value of their outstanding shares is at $14.2 million.
  • T2 Biosystems (NASDAQ:TTOO) shares declined by 4.99% to $0.38. The company's market cap stands at $63.2 million.
  • Qualigen Therapeutics (NASDAQ:QLGN) stock declined by 4.38% to $0.87. The company's market cap stands at $30.7 million.
  • Lannett (NYSE:LCI) shares decreased by 3.93% to $1.47. Lannett's trading volume hit 102.6K shares by close, accounting for 20.8% of its average volume over the last 100 days. The market value of their outstanding shares is at $63.6 million.
  • Relay Therapeutics (NASDAQ:RLAY) shares declined by 3.42% to $21.5. The company's market cap stands at $2.3 billion.
  • Cingulate (NASDAQ:CING) stock decreased by 2.95% to $1.98. The company's market cap stands at $22.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.